Ocular Therapeutix, Inc. (OCUL)
6.97
-0.34
(-4.65%)
USD |
NASDAQ |
Oct 30, 16:00
6.97
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Cash and Short Term Investments (Annual) : 737.06M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 737.06M |
| December 31, 2024 | 392.10M |
| December 31, 2023 | 195.96M |
| December 31, 2022 | 102.30M |
| December 31, 2021 | 164.16M |
| December 31, 2020 | 228.06M |
| December 31, 2019 | 54.44M |
| Date | Value |
|---|---|
| December 31, 2018 | 54.06M |
| December 31, 2017 | 41.54M |
| December 31, 2016 | 68.14M |
| December 31, 2015 | 105.06M |
| December 31, 2014 | 74.89M |
| December 31, 2013 | 17.50M |
| December 31, 2012 | 23.85M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| EyePoint, Inc. | 306.09M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Eli Lilly & Co. | 7.268B |
| Corcept Therapeutics, Inc. | 372.15M |
| Veru, Inc. | 18.32M |